These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7854714)

  • 21. [Anesthesiology alternatives for lobectomy with thoracotomy in a patient with allergy to multiple neuromuscular blockers].
    Granell M; Peña J; Ubeda J; Soriano J; Tatay J; Cantó A; Llorens J
    Rev Esp Anestesiol Reanim; 2003 Mar; 50(3):160-2. PubMed ID: 12708217
    [No Abstract]   [Full Text] [Related]  

  • 22. A review of neuromuscular blockade in the critically ill patient.
    Burry L; HoSang M; Hynes-Gay P
    Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of neuromuscular blocking agents in critical care nursing practice.
    Semonin-Holleran R
    Crit Care Nurs Q; 1993 May; 16(1):37-44. PubMed ID: 8504363
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuromuscular blockade in the intensive care unit.
    Lewis KS; Rothenberg DM
    Am J Health Syst Pharm; 1999 Jan; 56(1):72-5. PubMed ID: 10048882
    [No Abstract]   [Full Text] [Related]  

  • 25. Peripheral electrical stimulation: titrating neuromuscular blocking agent levels.
    Hill L
    Dimens Crit Care Nurs; 1995; 14(6):305-14. PubMed ID: 8631213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highlights in muscle relaxants.
    Leykin Y; Pellis T; Vincenti E
    Expert Rev Neurother; 2006 Dec; 6(12):1833-43. PubMed ID: 17181430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The undesirable effects of neuromuscular blocking drugs.
    Claudius C; Garvey LH; Viby-Mogensen J
    Anaesthesia; 2009 Mar; 64 Suppl 1():10-21. PubMed ID: 19222427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular blocking drugs in the intensive care unit: introductory remarks.
    Bion JF; Pollard BJ
    Intensive Care Med; 1993; 19 Suppl 2():S35. PubMed ID: 8106675
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute muscular weakness during childhood in cases of severe asthma due to the use of corticoids and neuromuscular blockers].
    Campistol Plana J; Gironell Carrero A; Cambra Lasaosa FJ; Colomer Oferil J; Luaces Cubells C; Martín Rodrigo JM
    An Esp Pediatr; 1996 Aug; 45(2):196-8. PubMed ID: 8967655
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of muscle relaxants in the ICU: nursing implications.
    Snider BS
    Crit Care Nurse; 1993 Dec; 13(6):55-60. PubMed ID: 8112097
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of a policy for patients receiving neuromuscular blocking agents.
    Earl G; McMahon MB; Bartley M; Mancini W; Becker S
    J Trauma Nurs; 1997; 4(3):76-81. PubMed ID: 9407819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring neuromuscular blockade in the intensive care unit: the peripheral nerve stimulator.
    Rowlee SC
    Heart Lung; 1999; 28(5):352-62; quiz 363-4. PubMed ID: 10486453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of neuromuscular blockade in the critically ill patient.
    Michaud D; Abbas M; Gélinas C
    Dynamics; 2002; 13(3):11. PubMed ID: 12640839
    [No Abstract]   [Full Text] [Related]  

  • 34. Complications of sedation and critical illness.
    Foster J
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):287-96. PubMed ID: 16115537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle weakness and difficulty in weaning from the ventilator in the critical care unit.
    Bolton CF
    Chest; 1994 Jul; 106(1):1-2. PubMed ID: 8020252
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
    Kleinpell R; Bedrosian C; McCormick L; Kremer M; Bujalski L; Bronsted R
    Am J Crit Care; 1996 Nov; 5(6):449-54. PubMed ID: 8922161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle relaxants in intensive care patients.
    Hinds CJ; Nagendran K; Honauar M; Coakley JH
    Crit Care Med; 1993 Sep; 21(9):1403-5. PubMed ID: 8370306
    [No Abstract]   [Full Text] [Related]  

  • 38. Residual neuromuscular block: rediscovering the obvious.
    Brull SJ; Naguib M; Miller RD
    Anesth Analg; 2008 Jul; 107(1):11-4. PubMed ID: 18635461
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathophysiological changes of the neuromuscular transmission in the critically ill patient.
    Khuenl-Brady KS
    Acta Anaesthesiol Scand Suppl; 1997; 111():108. PubMed ID: 9420975
    [No Abstract]   [Full Text] [Related]  

  • 40. Open forum--neuromuscular blockade to optimize ventilation is becoming common. How does your unit assess/monitor blockade level?
    Snook MM; Rohan J; Williams C; Schell H
    Crit Care Nurse; 1994 Oct; 14(5):113-4. PubMed ID: 7859461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.